13F HOLDINGS REPORT
Patient Square Capital LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000950123-25-002377
Total Value
$267.4M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | ROIV | 12,480,000 | $147.6M | 55.22% |
| 2 | LIQUIDIA CORPORATION | LQDA | 1,860,371 | $21.9M | 8.18% |
| 3 | INSMED INC | INSM | 307,167 | $21.2M | 7.93% |
| 4 | CULLINAN THERAPEUTICS INC | CGEM | 878,897 | $10.7M | 4.00% |
| 5 | EYEPOINT PHARMACEUTICALS | EYPT | 1,410,331 | $10.5M | 3.93% |
| 6 | NURIX THERAPEUTICS, INC. | NRIX | 446,296 | $8.4M | 3.14% |
| 7 | INTRA-CELLULAR THERAPIES INC. | 46116X101 | 71,990 | $6.0M | 2.25% |
| 8 | ENLIVEN THERAPEUTICS INC | ELVN | 224,038 | $5.0M | 1.89% |
| 9 | GERON CORPORATION | GERN | 1,321,268 | $4.7M | 1.75% |
| 10 | OCULAR THERAPEUTIX, INC. | OCUL | 470,919 | $4.0M | 1.50% |
| 11 | AGIOS PHARMACEUTICALS, INC. | AGIO | 121,732 | $4.0M | 1.50% |
| 12 | PHARVARIS N V | PHVS | 207,603 | $4.0M | 1.49% |
| 13 | DISC MEDICINE, INC. | IRON | 56,400 | $3.6M | 1.34% |
| 14 | SPRINGWORKS THERAPEUTICS, INC. | 85205L107 | 93,137 | $3.4M | 1.26% |
| 15 | ALLOGENE THERAPEUTICS, INC. | ALLO | 1,489,909 | $3.2M | 1.19% |
| 16 | MIRUM PHARMACEUTICALS, INC. | MIRM | 64,900 | $2.7M | 1.00% |
| 17 | INTELLIA THERAPEUTICS, INC. | NTLA | 215,981 | $2.5M | 0.94% |
| 18 | ARVINAS, INC. | ARVN | 86,627 | $1.7M | 0.62% |
| 19 | SCHOLAR ROCK HOLDING CORPORATION | SRRK | 32,000 | $1.4M | 0.52% |
| 20 | ASTRIA THERAPEUTICS INC | 04635X102 | 105,057 | $939,210 | 0.35% |